1. 24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy. (December 2020) Authors: Rossi, I.; D'Ardes, D.; Vezzani, F.; Guagnano, M.T.; Santilli, F.; Cipollone, F.; Bucci, M. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection. (August 2021) Authors: Rossi, I.; D'Ardes, D.; Bucciarelli, B.; Allegra, M.; Guagnano, M.T.; Santilli, F.; Bianco, F.; Marchioni, M.; Di Nicola, M.; Cipollone, F.; Bucci, M. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.02.4 OXIDATIVE STRESS AND THROMBOXANE-DEPENDENT PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE (IBD): EFFECTS OF ANTI-TNF-ALFA TREATMENT. (24th February 2016) Authors: Di Sabatino, A.; Santilli, F.; Guerci, M.; Giuffrida, P.; Aronico, N.; Simeone, P.; Caprotti, A.; Salvatore, C.; Tripaldi, R.; Liani, R.; Ardizzone, S.; Massari, A.; Balduini, A.; Malara, A.; Corazza, G.R.; Davì, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Platelet-associated tissue factor as a new mechanism involved in the prothrombotic phenotype of stable angina patients with type-2 diabetes mellitus (T2DM). (September 2016) Authors: Rossetti, L.; Canzano, P.; Mapelli, M.; Trabattoni, D.; Santilli, F.; Davì, G.; Lualdi, A.; Tremoli, E.; Camera, M. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗